The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2024 | Areas of research currently being explored for ultra-high-risk multiple myeloma
Jill Corre, PhD, The Cancer University Institute of Toulouse Oncopole, Toulouse, France, discusses areas of research currently being explored for ultra-high-risk multiple myeloma (MM). She focuses on patients with aggressive sub-clonal disease, the role of the immune system, and the unmet needs of those with extramedullary disease. This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
